Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A

Biochemical Pharmacology

Volumn 38, Issue 24, 1989, Pages 4467-4475

  Coley, Helen M ^a   Twentyman, Peter R ^a   Workman, Paul ^a  

^a MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4' IODOESORUBICIN; 9 DEACETYL 9 METHYLIDARUBICIN; ACLARUBICIN; ANTHRACYCLINE DERIVATIVE; CYCLOSPORIN A; DOXORUBICIN; VERAPAMIL;

ANIMAL CELL; ARTICLE; BREAST TUMOR; CANCER CELL; CELL CULTURE; CELL LINE; DRUG ACCUMULATION; DRUG RESISTANCE; HUMAN; HUMAN CELL; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL CELL CARCINOMA;

ACLARUBICIN; ANIMAL; ANTIBIOTICS, ANTHRACYCLINE; CYCLOSPORINS; DOXORUBICIN; DRUG COMBINATIONS; DRUG RESISTANCE; HUMAN; MICE; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0024819898     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(89)90658-8     Document Type: Article

References (40)

1. Uptake and retention of adriamycin and daunomycin by sensitive and anthracycline-resistant sublines of P388 leukaemia
2. Reduced permeability in CHO cells as a mechanism of resistance to colchicine
3. Active outward transport of daunomycin in resistant Ehrlich ascites tumour cells
4. Reduced drug accumulation in multiply drug resistant human KB carcinoma cell lines
5. Mechanisms of cross-resistance between vincristine and daunorubicin in Ehrlich ascites tumor cells
6. Internal duplication and homology with bacterial transport proteins in the mdr 1 (P-glycoprotein) gene from multidrug resistant human cells
7. Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport systems
8. Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein
9. Increased mdr gene expression and decreased drug accumulation in MDR human melanoma cells
10. Increased vinblastine binding to membrane vesicles from multidrug resistant KB cells
11. Certain calcium channel blockers bind specifically to multidrug resistant human KB or carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein
12. Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers
13. Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labelling of P-glycoprotein
14. Identification of anthracyclines and related agents which retain preferential activity over adriamycin in multi-drug resistant cell lines, and further resistance modification by verapamil and cyclosporin A
15. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine
16. Verapamil reversal of doxorubicin resistance in multidrug resistant human myeloma cells and association with drug accumulation and DNA damage
17. Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells
18. Resistance to anthrapyrazoles and anthracyclines in multidrug resistant P388 murine leukaemia cells: reversal by calcium channel blockers and calmodulin antagonists
19. Increased accumulation of vincristine and adriamycin in drug resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors
20. Derivation and characterisation of a adriamycin resistant lines of human lung cancer cells
21. The in vitro effects and cross-resistance patterns of some novel anthracyclines
22. A fluorimetric assay for daunomycin and adriamycin in animal tissues
23. Comparative nuclear and cellular incorporation of daunorubicin, doxorubicin, carminomycin, marcellomycin, aclacinomycin A and AD32 in daunorubicin sensitive and resistant Ehrlich ascites in vitro
24. Membrane transport of anthracyclines
25. 9-Alkyl anthracyclines. Absence of crossresistance to adriamycin in human and murine cell cultures
26. Rapid chemosenstivity testing of human lung tumour cells using the MTT assay
27. Effect of verapamil and other agents on the redistribution of anthracyclines and on reversal of drug resistance
28. Cyclosporin A enhances daunorubicin efficacy in Erhlich ascites carcinoma and murine hepatoma 129
29. Manipulation of drug accumulation: mechanisms to overcome resistance
30. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux and P-glycoprotein in cloned cell lines of ADM-sensitive and resistant P388 leukemia
31. Correlations between anthracycline resistance, drug accumulation and membrane glycoprotein patterns in solid tumors of mice
32. Isolation and characterisation of adriamycin resistant HL-60 cells which are not defective in the initial accumulation of drug
33. Mechanisms of multidrug resistance in HL-60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug
34. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma line
35. Multidrug resistance in a human small cell line selected in adriamycin
36. r, 22,000 calcium binding protein (sorcin) associated with multidrug resistance and its detection with monoclonal antibodies
37. Adriamycin resistance in HL-60 cells and accompanying modification of a surface membrane protein contained in drug-sensitive cells
38. Association of sorcin with drug resistance in L1210 cells